Laddar...
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer
The addition of lapatinib (Tykerb/Tyverb) to capecitabine (Xeloda) delays disease progression more effectively than capecitabine monotherapy in women with previously treated HER2+ metastatic breast cancer (MBC). The quality-adjusted time without symptoms of disease or toxicity of treatment (Q-TWiST)...
Sparad:
| Huvudupphovsmän: | , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2008
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2528149/ https://ncbi.nlm.nih.gov/pubmed/18728660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6604501 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|